Lung Cancer Symposium: Update on Diagnosis and Management
Roswell Park Cancer Institute is pleased to present an educational program developed to update medical oncologists, pulmonologists, primary care physicians and advanced practice practitioners on a prominent clinical problem: Evaluating lung nodules and the related diagnosis and treatment of lung cancer. In this rapidly evolving field, you will learn current concepts to better manage your patients.
Following this program, participants should be able to:
- Describe the malignant potential of small nodules, especially those appearing semi-solid radiographically.
- Explain how navigational bronchoscopy, combined with radial endobronchial ultrasound (EBUS) can further complement diagnostic evaluation of lung nodules, limiting exposure of patients to less useful techniques.
- Recognize how tumors of central airways can be effectively managed by advanced bronchoscopic techniques.
- State the options for lung sparing techniques.
- Discuss the present state of, and future outlook for, lung cancer immunotherapy.
- Explain the requirements, outcomes and risks associated with stereotactic body radiation therapy (SBRT) versus the standard radiotherapy for treatment of lung cancers.
Dates: Saturday, February 25, 2017
Location: Hyatt Place Buffalo/Amherst, 5020 Main Street, Amherst, NY 14226
Time: 8 a.m. - 12:30 p.m.
Anthony L. Picone, MD, PhD, MBA
Roswell Park Cancer Institute is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
Roswell Park Cancer Institute designates this live educational activity for a maximum of 3.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.